InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

SYBX Stock Earnings: Synlogic Beats EPS for Q2 2024

By InvestorPlace Earnings

SYBX stock results show that Synlogic beat analyst estimates for earnings per share the second quarter of 2024.

GLUE Stock Earnings: Monte Rosa Therapeutics Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

GLUE stock results show that Monte Rosa Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

CABA Stock Earnings: Cabaletta Bio Misses EPS for Q2 2024

By InvestorPlace Earnings

CABA stock results show that Cabaletta Bio missed analyst estimates for earnings per share the second quarter of 2024.

CGEM Stock Earnings: Cullinan Therapeutics Misses EPS for Q2 2024

By InvestorPlace Earnings

CGEM stock results show that Cullinan Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

HOWL Stock Earnings: Werewolf Therapeutics Misses EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

HOWL stock results show that Werewolf Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Load More